TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Merck, Glaxo Vaccines Get Nod An FDA panel said that fragments of pig viruses found in vaccines used to protect infants against rotavirus didn't appear to cause health risks. online.wsj.com |
Parents Seek Vaccination Exemptions Some parents in Greater New York are so concerned about the safety of childhood vaccines that they are seeking to exempt their children from school immunization requirements. online.wsj.com |
Genzyme Giving Sanofi-Aventis the Cold Shoulder? Derek Lowe submits: That's what Bloomberg is reporting. Meanwhile, the Wall Street Journal reported that GlaxoSmithKline (GSK) has expressed interest in the recent past, and that J&J (JNJ) might get involved as well. If a deal goes through, no matter who ends up making it, it'll be a lot more expensive than it looked like at first. But isn't that ever the way in M&A? The problem is, everyone except the buyer has a great interest in seeing things go off at the highest possible price.Complete Story » seekingalpha.com |
Hedge Fund Manager Takes Bid Directly to Cypress Shareholders The Burrill Report submits: By Michael FitzhughRamius, a hedge fund manager trying to gain control of Cypress Bioscience (CYPB), is taking its $148 million hostile bid directly to Cypress shareholders, bypassing the company's management after it rejected a lower bid in August. Complete Story » seekingalpha.com |
Several Scenarios Ahead of the FDA's Imminent Decision on Alexza M.E. Garza submits: By Patrick CrutcherBiotech investors should be ready for a big week. With multiple FDA decisions on the line, there should be ample trading and investing opportunities out there. Let's focus on one of these events in particular.Complete Story » seekingalpha.com |